With the aim of creating an ecosystem for the creation of nucleic acid drugs, we will host a seminar entitled “NATiAS Oligonucleotide Therapeutic Day 2022 Spring”(in Japanese)…read more

Our CEO, Mr. Masanori Kataoka, will give a presentation at Innovation Field 2022 (co-hosted by Mizuho Securities Co., Ltd. and KPMG AZSA LLC), which will be held online from Tuesday, March 15 to Thursday, March 17, 2022…read more

We are pleased to announce that we will be exhibiting at the 3rd Kyoto University Life Science Showcase @ San Diego 2022…read more